Goldman Sachs (GS) ended the recent trading session at $379.75, demonstrating a -0.58% swing from the preceding day's closing price. The stock trailed the S&P 500, which registered a daily loss of 0.07%.The the stock of investment bank has risen by 5.3% in the past month, leading the Finance sector's gain of 1.65% and the S&P 500's gain of 3.98%.Investors will be eagerly watching for the performance of Goldman Sachs in its upcoming earnings disclosure. The company's earnings report is set to be unveiled on ...

About this content About Sean Mason Sean Mason is a Senior Journalist at Proactive, having researched and written about Canadian and US equities for 20 years. Sean graduated from the University of Toronto with a BA in history and economics and has also passed the Canadian Securities Course. He previously worked at Investors Digest of Canada, Stockhouse, and SmallCapPower.com. Read more About the publisher Proactive financial news and online broadcast teams provide fast, accessible, informative and action ...

Goldman Sachs Group Inc (NYSE:GS) is among the bank names that will announce quarterly results to start the year, slated for release before the open on Tuesday, Jan. 16. Last seen 1.4% lower at $376.66, GS is sluggish to start the year, already down 2.3% in 2024. The equity also just dipped below recent guidance higher at its 20-day moving average, though it maintains a slim 3.4% year-over-year lead.The bank stock has a lackluster post-earnings track record, finishing five of its last eight next-day session ...

In its upcoming report, Goldman Sachs (GS) is predicted by Wall Street analysts to post quarterly earnings of $3.79 per share, reflecting an increase of 14.2% compared to the same period last year. Revenues are forecasted to be $10.89 billion, representing a year-over-year increase of 2.9%.Over the past 30 days, the consensus EPS estimate for the quarter has been adjusted upward by 2.9% to its current level. This demonstrates the covering analysts' collective reassessment of their initial projections during ...

About this content About Sean Mason Sean Mason is a Senior Journalist at Proactive, having researched and written about Canadian and US equities for 20 years. Sean graduated from the University of Toronto with a BA in history and economics and has also passed the Canadian Securities Course. He previously worked at Investors Digest of Canada, Stockhouse, and SmallCapPower.com. Read more About the publisher Proactive financial news and online broadcast teams provide fast, accessible, informative and action ...

Goldman Sachs (GS) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2023. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price.The earnings report, which is expected to be released on January 16, 2024, might help the stock move higher if these key numbers are better tha ...

The Goldman Sachs Group, Inc. (GS) is slated to release fourth-quarter and full-year 2023 earnings on Jan 16, before market open. The company is expected to have witnessed year-over-year growth in quarterly revenues and earnings.In the last reported quarter, Goldman’s earnings surpassed the Zacks Consensus Estimate. Its results have been supported by strong Fixed Income, Currency and Commodities (FICC), financing revenues as well as strength in the consumer banking business. However, higher expenses posed h ...

The Goldman Sachs Group, Inc. (GS) is being considered to become the authorized participant (AP) for the spot Bitcoin exchange-traded fund (ETF), which Grayscale and BlackRock Inc. (BLK) are planning to launch.Apart from GS, JPMorgan Chase & Co. (JPM) is being considered as a potential AP for the ETF. This was first reported by Coindesk.BLK became the first asset manager to file for the spot Bitcoin ETF in June 2023, paving the way for a wave of filings by other asset managers like Fidelity, Invesco and Wis ...

Goldman Sachs Group Inc. (GS) continued to hold its position as the leading provider of merger advice for the seventh running year. Per data compiled by Bloomberg, Goldman advised on 235 mergers and acquisitions (M&A) announced in 2023 with an aggregate value of more than $671 billion.With this, the bank had a 31% market share of the global merger advisory, surpassing JPMorgan Chase & Co. (JPM) . JPM was leading in merger advisory at the mid-point of 2023. Markedly, GS’s market share has increased against i ...

投中网  >  生物医药  >  正文 高盛首只生命科学策略基金完成6.5亿美元募集 投中网   |   投中网 2024-01-03 19:00:00 此基金为高盛资产管理首只生命科学策略基金，亦是该策略史上最大的首发私募成长基金之一。 2024年1月3日,  高盛资产管理今日宣布，旗下West Street生命科学一期基金（“生命科学一期”或“该基金”）完成最终募集。这是高盛资产管理生命科学投资策略的首发基金。 生命科学一期超额完成募集，共计募得6.5 亿美元。其投资者涵盖了全球多元的机构投资者、战略投资者、高净值人士及高盛员工等。该基金是生命科学投资策略领域史上最大的首发私募成长基金之一。 该基金在高盛资产管理生命科学投资主管阿米特·辛哈（Amit Sinha）领导下，由成立于2021年的生命科学投资团队管理。 该团队拥有数十年的行业投资经验，将利用高盛平台的广泛资源来寻找差异化投资机会，为公司赋能，共创价值。此外，由平均从业经验超过24年的学术专家、临床医生、科学家和企业家组成的顾问委员会亦为该投资团队提供建议。 该策略专注于生命科学领域的成长型私募股权投资，重点关注具有生命科学工具和诊断技术 ...